Search Results
Feb 19, 2026, 02:42 ET Evolving forward as Elicron
125 years of experience that our customers can truly benefit from," says David Ekberg, CEO of Elicron.Elicron's manufacturing sites and R&D operations are in three different continents: Europe, North America and Asia. Across this global organization of around 350 specialists, Elicron brings
More news about: Elicron
Feb 19, 2026, 02:40 ET Evolving forward as Elicron
125 years of experience that our customers can truly benefit from," says David Ekberg, CEO of Elicron.Elicron's manufacturing sites and R&D operations are in three different continents: Europe, North America and Asia. Across this global organization of around 350 specialists, Elicron brings
More news about: Elicron
Feb 19, 2026, 02:30 ET vivo V70 Goes Global with a New Sleek Look, more powerful ZEISS Imaging and a Smarter OriginOS
world-class corporation.While bringing together and developing the best local talents to deliver excellence, vivo is supported by a network of R&D centers in Shenzhen, Dongguan, Nanjing, Beijing, Hangzhou, Shanghai, Xi'an and more cities, focusing on the development of state-of-the-art consumer
More news about: vivo
Feb 19, 2026, 02:20 ET GomSpace Reports an all-time high Q4 and a full year of significant growth
https://news.cision.com/gomspace-a-s/r/gomspace-reports-an-all-time-high-q4-and-a-full-year-of-significant-growth,c4309882The following files are available for download:
More news about: GomSpace A/S
Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
doi:10.21037/tp.2019.07.10 Data on file; estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242.
More news about: Prolacta Bioscience
Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
doi:10.21037/tp.2019.07.10 Data on file; estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242.
More news about: Prolacta Bioscience
Feb 19, 2026, 01:32 ET CGTN: Kinh tế tư nhân: Nhân tố then chốt thúc đẩy các ưu tiên kinh tế của Trung Quốc năm 2026 và những năm tiếp theo
xe dẫn đường tự động hạng nặng, phá vỡ sự phụ thuộc vào công nghệ nước ngoài. Nhờ vào tầm nhìn thị trường sắc bén và đầu tư bền bỉ cho hoạt động R&D, DJI đã trở thành doanh nghiệp dẫn đầu toàn cầu trong lĩnh vực máy bay không người lái.Bên cạnh việc thúc đẩy tiêu dùng và đổi mới sáng
More news about: CGTN
Feb 19, 2026, 00:52 ET SEMIFIVE Partners with Niobium to Develop FHE Accelerator, Driving U.S. Market Expansion
speeds, processing sensitive information in the clear will no longer be acceptable. With SEMIFIVE and Samsung Foundry, we're translating years of R&D into production-ready silicon for encrypted cloud and AI environments. This represents the next step in our transition from prototype systems to accelerators
More news about: SEMIFIVE
Feb 19, 2026, 00:38 ET 'The Blue, The Gold, and The Gray' offers a sweeping perspective on America's formation, expansion and division
1492 to 1865"By Gary R. Goodson Sr. B.S. & M.S.Softcover | 8.5 x 11in | 222 pages | ISBN 9781665783743E-Book | 222 pages | ISBN 9781665783736Available at Amazon and Barnes & NobleAbout the AuthorGary R. Goodson Sr. B.S. & M.S. is
More news about: Archway Publishing
Feb 19, 2026, 00:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
doi:10.21037/tp.2019.07.10 Data on file; estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242.
More news about: Prolacta Bioscience
Feb 18, 2026, 22:42 ET Bone Wax Market to Reach $73 Million, Globally, by 2033 at 3.2% CAGR: Allied Market Research
orthopedic and neurosurgical applications, where patient safety and faster recovery are priorities. Rising adoption of bioabsorbable materials and ongoing R&D efforts are expected to further strengthen this segment during the forecast period.The orthopedic surgery segment accounted for the largest
More news about: Allied Market Research
Feb 18, 2026, 17:27 ET Borr Drilling Limited Announces Fourth Quarter 2025 Results
https://news.cision.com/borr-drilling-limited/r/borr-drilling-limited-announces-fourth-quarter-2025-results,c4309781The following files are available for download:
More news about: Borr Drilling Limited
Feb 18, 2026, 17:00 ET OceanaGold Reports Mineral Reserves and Resources for the Year Ended 2025
dated March 28, 2024 with an effective date of December 31, 2023, prepared by D. Carr, D. Londono, J. Moore and B. Drury (OceanaGold), L. Standridge and R. Cook (Call & Nicholas, Inc.), J. Newton Janney-Moore and W. Lucas Kingston (NewFields Mining & Technical Services LLC) and M. Sullivan and B.
More news about: OceanaGold Corporation
Feb 18, 2026, 16:15 ET EOG Resources to Present at Upcoming Conference
Raymond James 47th Annual Institutional Investors Conference at 7:05 a.m. Central time (8:05 a.m. Eastern time) on Tuesday, March 3. Jeffrey R. Leitzell, Executive Vice President and Chief Operating Officer, will present on behalf of EOG. Please visit the
More news about: EOG Resources, Inc.
Feb 18, 2026, 16:05 ET BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
continues to focus on strengthening its balance sheet and delivering value to shareholders.Bausch Health (excluding Bausch + Lomb) R&D UpdateLarsucosterol (Epigenetic Modulator): FDA Breakthrough Therapy Designation for treatment of Alcohol-Associated
More news about: Bausch Health Companies Inc.
Feb 18, 2026, 15:49 ET Atlantic Biomass, LLC Announces Duel Pathway System to Affordably Produce Sustainable Aviation Fuels (SAF) and Renewable Bioproducts
for business agreements. Are You Ready for Take-Off?An illustrated version of this press release as well as detailed R&D results and additional information is available from Atlantic Biomass, LLC.Atlantic Biomass, LLC, a small business located in Frederick,
More news about: Atlantic Biomass, LLC
Feb 18, 2026, 15:45 ET Experienced Health Care Attorney Terra Parten Joins Williams Mullen
RICHMOND, Va., Feb. 18, 2026 /PRNewswire/ -- Williams Mullen is pleased to announce that Terra R. Parten has joined the firm's Health Care Section, one of the largest health care practices in Virginia. Williams Mullen's health care practice advises
More news about: Williams Mullen
Feb 18, 2026, 15:27 ET a21 ACQUIRES EQUITY STAKE IN TWO12, FORMING A STRATEGIC PARTNERSHIP TO UNITE CULINARY TALENT AND GLOBAL EXPERIENTIAL PLATFORMS
a21 today announced it acquired an equity stake in Two12, the culinary-focused management company founded by Scott R. Feldman and backed by Paradigm Talent Agency and its subsidiary, Paradigm Media Entertainment. The strategic partnership unites talent representation
More news about: a21
Feb 18, 2026, 15:18 ET /C O R R E C T I O N -- Stateside Associates/
More news about: Stateside Associates
Feb 18, 2026, 15:11 ET /C O R R E C T I O N -- Army & Air Force Exchange Service/
More news about: Army & Air Force Exchange Service
Feb 18, 2026, 14:39 ET Catalight Researcher Awarded NIH Grant to Study Program Meant to Enhance Educator Training on Supports for Autistic Students
Feb. 18, 2026 /PRNewswire/ -- A Catalight researcher has been awarded a $4.5 million National Institute of Health (NIH) R01 grant to study RUBIES, a program aimed at reducing challenging behaviors among autistic elementary students. In partnership with Dr. Jill Locke from
More news about: Catalight Foundation, a California non-profit corporation
Feb 18, 2026, 14:30 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-s-biologics-license-application--bla--for-imlifidase-accepted-by-the-fda,c4309758The following files are available for download:
More news about: Hansa Biopharma AB
Feb 18, 2026, 14:28 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA
https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-s-biologics-license-application--bla--for-imlifidase-accepted-by-the-fda,c4309758The following files are available for download:
More news about: Hansa Biopharma AB
Feb 18, 2026, 13:45 ET Draper and the Northeast Microelectronics Coalition (NEMC) Announce Chip Design and Packaging Services to Accelerate Technology Commercialization
https://forms.office.com/r/EX4DpkWy9w.About DraperDraper is a non-profit research, development, and manufacturing company that solves some of the nation's
More news about: Draper Laboratory